Literature DB >> 24010912

PET/CT in gynecologic malignancies.

Jacqueline Brunetti1.   

Abstract

Ovarian cancer and malignancies of the uterine cervix and corpus are the most commonly encountered gynecologic neoplasms in clinical practice. Although of little value in both diagnosis and early-stage gynecologic malignancy, fluorodeoxyglucose-PET and PET/computed tomography provide accurate detection of metastatic disease in advanced malignancy and better delineation of recurrent disease compared with conventional imaging.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Endometrial cancer; FDG-PET; Ovarian cancer; PET/CT

Mesh:

Substances:

Year:  2013        PMID: 24010912     DOI: 10.1016/j.rcl.2013.05.006

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  4 in total

Review 1.  Clinical and research applications of simultaneous positron emission tomography and MRI.

Authors:  F Fraioli; S Punwani
Journal:  Br J Radiol       Date:  2013-11-14       Impact factor: 3.039

2.  Imaging in endometrial carcinoma.

Authors:  Silvana C Faria; Tara Sagebiel; Aparna Balachandran; Catherine Devine; Chandana Lal; Priya R Bhosale
Journal:  Indian J Radiol Imaging       Date:  2015 Apr-Jun

Review 3.  Positron emission tomography image-guided drug delivery: current status and future perspectives.

Authors:  Rubel Chakravarty; Hao Hong; Weibo Cai
Journal:  Mol Pharm       Date:  2014-06-04       Impact factor: 4.939

4.  The risk of distant metastases in patients with gynecologic cancers after surgery: a population-based study.

Authors:  Yi-Hsuan Hsiao; Pei-Ni Chen; Min-Chien Hsin; Po-Hui Wang; Jing-Yang Huang; Shun-Fa Yang
Journal:  Aging (Albany NY)       Date:  2021-12-16       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.